Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propionyl-L-Carnitine in Ulcerative Colitis
NCT01026857Phase 2Completed
- Sponsor
- Sigma-Tau
- Start
- May 2006
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of propionyl-L-carnitine in ulcerative colitis (UC), sponsored by Sigma-Tau. Started May 2006; status: completed.
02
Drugs
propionyl-L-carnitine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01026857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026857.